Drug Discovery Research 2006
DOI: 10.1002/9780470131862.ch19
|View full text |Cite
|
Sign up to set email alerts
|

Bridging Bench to Clinic: Roles of Animal Models for Post‐Genomics Drug Discovery on Metabolic Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…Microarray technology has developed rapidly and numerous text books and reviews have been published addressing the critical issues of microarray experimental design,48 data analyses,49 and the application of microarray technology to investigate normal physiology50 and disease pathogenesis 51,52. Microarrays have been developed for a wide variety of microbial pathogens and host systems, but the application of this technology to functional genomic studies is very recent 5358. A variety of commercial microarrays are now available for different species and microarrays representing specific cell signaling pathways or biological functions are being used as routine tools to address hypotheses in basic research and clinical trials.…”
Section: Omics At a Glancementioning
confidence: 99%
“…Microarray technology has developed rapidly and numerous text books and reviews have been published addressing the critical issues of microarray experimental design,48 data analyses,49 and the application of microarray technology to investigate normal physiology50 and disease pathogenesis 51,52. Microarrays have been developed for a wide variety of microbial pathogens and host systems, but the application of this technology to functional genomic studies is very recent 5358. A variety of commercial microarrays are now available for different species and microarrays representing specific cell signaling pathways or biological functions are being used as routine tools to address hypotheses in basic research and clinical trials.…”
Section: Omics At a Glancementioning
confidence: 99%